Literature DB >> 17493048

Why do we need an Addiction supplement focused on methamphetamine?

Richard A Rawson1, Timothy P Condon.   

Abstract

Methamphetamine is a substantial public health problem in many communities in the United States and in other parts of the world. In order to bring new knowledge about methamphetamine to policy makers, clinicians and researchers, this volume has compiled a set of articles containing new information about the drug and its effects. The articles contain information presented by researchers at two special methamphetamine meetings sponsored by the National Institute on Drug Abuse in 2005.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17493048     DOI： 10.1111/j.1360-0443.2006.01781.x

Source DB:  PubMed          Journal:  Addiction        ISSN： 0965-2140            Impact factor:   6.526


  30 in total

1.  Gestation time-dependent pharmacokinetics of intravenous (+)-methamphetamine in rats.

Authors:  Sarah White; Elizabeth Laurenzana; Howard Hendrickson; W Brooks Gentry; S Michael Owens
Journal:  Drug Metab Dispos       Date:  2011-06-01       Impact factor: 3.922

2.  Prior methamphetamine self-administration attenuates serotonergic deficits induced by subsequent high-dose methamphetamine administrations.

Authors:  Lisa M McFadden; Madison M Hunt; Paula L Vieira-Brock; Janice Muehle; Shannon M Nielsen; Scott C Allen; Glen R Hanson; Annette E Fleckenstein
Journal:  Drug Alcohol Depend       Date:  2012-05-28       Impact factor: 4.492

3.  Effect of modafinil on learning and task-related brain activity in methamphetamine-dependent and healthy individuals.

Authors:  Dara G Ghahremani; Golnaz Tabibnia; John Monterosso; Gerhard Hellemann; Russell A Poldrack; Edythe D London
Journal:  Neuropsychopharmacology       Date:  2011-02-02       Impact factor: 7.853

Review 4.  Potential adverse effects of amphetamine treatment on brain and behavior: a review.

Authors:  S M Berman; R Kuczenski; J T McCracken; E D London
Journal:  Mol Psychiatry       Date:  2008-08-12       Impact factor: 15.992

Review 5.  The sigma-1 receptor as a regulator of dopamine neurotransmission: A potential therapeutic target for methamphetamine addiction.

Authors:  Danielle O Sambo; Joseph J Lebowitz; Habibeh Khoshbouei
Journal:  Pharmacol Ther       Date:  2018-01-31       Impact factor: 12.310

6.  A comparison of amphetamine- and methamphetamine-induced locomotor activity in rats: evidence for qualitative differences in behavior.

Authors:  Darien A Hall; Jessica J Stanis; Hector Marquez Avila; Joshua M Gulley
Journal:  Psychopharmacology (Berl)       Date:  2007-09-17       Impact factor: 4.530

Review 7.  Abuse of amphetamines and structural abnormalities in the brain.

Authors:  Steven Berman; Joseph O'Neill; Scott Fears; George Bartzokis; Edythe D London
Journal:  Ann N Y Acad Sci       Date:  2008-10       Impact factor: 5.691

8.  Extra-medical stimulant dependence among recent initiates.

Authors:  Megan S O'Brien; James C Anthony
Journal:  Drug Alcohol Depend       Date:  2009-06-09       Impact factor: 4.492

9.  Fast uptake and long-lasting binding of methamphetamine in the human brain: comparison with cocaine.

Authors:  Joanna S Fowler; Nora D Volkow; Jean Logan; David Alexoff; Frank Telang; Gene-Jack Wang; Christopher Wong; Yeming Ma; Aarti Kriplani; Kith Pradhan; David Schlyer; Millard Jayne; Barbara Hubbard; Pauline Carter; Donald Warner; Payton King; Colleen Shea; Youwen Xu; Lisa Muench; Karen Apelskog
Journal:  Neuroimage       Date:  2008-07-22       Impact factor: 6.556

10.  White-matter abnormalities in brain during early abstinence from methamphetamine abuse.

Authors:  Marc C Tobias; Joseph O'Neill; Matthew Hudkins; George Bartzokis; Andrew C Dean; Edythe D London
Journal:  Psychopharmacology (Berl)       Date:  2010-01-27       Impact factor: 4.530
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.